Author

Sandra Erichsen

Paracelsus Medical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1

Frequent Co-Authors

Andreas NitscheiD· 1 shared Christian DrosteniD· 1 shared Georg HerrleriD· 1 shared Hannah Kleine‐Weber· 1 shared Marcel A. MülleriD· 1 shared Markus HoffmanniD· 1 shared Nadine KrügeriD· 1 shared Nai‐Huei WuiD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Andreas NitscheORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S. Schiergens, Georg Herrler, Nai‐Huei Wu, Andreas Nitsche, Marcel A. Müller, Christian Drosten, Stefan Pöhlmann

The paper shows that 2019-nCoV uses ACE2 and TMPRSS2 for cell entry, identifies TMPRSS2 as a therapeutic target, and demonstrates neutralization by SARS patient serum.

Cell · Mar 8, 2020Peer-reviewedMolecular Biology